🇺🇸 FDA
Patent

US 8501182

Monoclonal antibodies that react with the capsule of Bacillus anthracis

granted A61KA61K2039/505A61K39/07

Quick answer

US patent 8501182 (Monoclonal antibodies that react with the capsule of Bacillus anthracis) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2039/505, A61K39/07, A61K39/3955, A61K39/40